Home › Medical › Progesterone during transition
Progesterone during transition
Progesterone is a natural female hormone produced in the second half of the menstrual cycle and during pregnancy by the ovaries and placenta.
Background
Progesterone is a natural female hormone produced in the second half of the menstrual cycle and during pregnancy by the ovaries and placenta. In transgender care it is sometimes added to feminising hormone therapy.
Claims and evidence
Effects on breast formation, libido, mood and sleep are proposed. The Endocrine Society guideline (2017) and the WPATH Standards of Care version 8 (2022) note that the scientific substantiation for these effects is limited and inconclusive. Prescribing is partly based on patient experience.
Risks and considerations
Progesterone can cause fatigue, mood complaints and increased thrombosis risk. When added to estrogen, consultation with the prescribing physician on indication and monitoring is important.
Sources
Hembree, W.C., Cohen-Kettenis, P.T., Gooren, L., et al. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons. Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903. doi:10.1210/jc.2017-01658
Coleman, E., Radix, A.E., Bouman, W.P., et al. (2022). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(sup1), S1–S259. doi:10.1080/26895269.2022.2100644